| 股號 / 名稱 | 營收 | 稅後淨利 |
| ABBV 艾伯維 | 466,623,269,375.13 | 26,886,062,091.12 |
| AZN AstraZeneca PLC | 413,699,491,812.27 | 71,130,601,163.4 |
| BMY 施貴寶 | 387,139,716,882.45 | -388,542,751,676.04 |
| AMGN 美國安進 | 267,424,957,401.48 | 25,026,225,271.71 |
| GILD 吉利德科學 | 218,155,596,045.18 | -136,094,374,978.23 |
| REGN 雷傑納榮製藥 | 112,056,799,805.26 | 37,836,259,224.35 |
| MRNA 莫德納 | 91,719,321,041.43 | 7,080,431,400.21 |
| VRTX 福泰製藥 | 82,149,318,600.5 | 31,610,700,186.74 |
| BIIB Biogen Inc | 74,736,074,295.77 | 12,836,136,925.54 |
| ILMN Illumina Inc | 36,609,419,497.86 | -5,710,025,322.75 |
| INCY 英賽德 | 28,742,277,123.04 | 5,532,133,562.41 |
| ARGX argenx SE | 24,035,160,647.98 | -5,606,070,233.16 |
| BIO.B Bio Rad Laboratories Inc | 22,226,159,368.3 | 11,410,523,060.39 |
| BMRN Biomarin Pharmaceutical Inc | 21,170,587,772.78 | 2,892,927,229.52 |
| EXAS Exact Sciences Corp | 21,107,027,033.76 | -1,623,800,686.93 |
| BGNE Beigene Ltd | 20,699,951,171.32 | -11,992,782,499.73 |
| QGEN Qiagen NV | 16,613,302,362.18 | 3,186,650,932.12 |
| EXEL Exelixis Inc | 15,650,428,949.19 | 2,790,342,546.01 |
| ALNY Alnylam Pharmaceuticals Inc | 14,347,433,799.25 | -4,498,521,092.84 |
| SRPT Sarepta Therapeutics Inc | 12,946,454,614.78 | 1,489,664,034.92 |
| ALKS Alkermes Plc | 12,316,524,621.17 | 9,011,366,192.07 |
| BEAM Beam Therapeutics Inc | 10,316,939,010.58 | 4,659,282,777.22 |
| HCM HUTCHMED (China) Ltd | 9,955,837,009.17 | -2,230,955,836.67 |
| NVAX Novavax Inc | 9,506,115,414.75 | -5,820,604,041.71 |
| EBS Emergent BioSolutions Inc | 9,025,102,881.56 | -1,615,121,448.44 |
| TECH Bio-Techne Corp | 8,894,522,759.61 | 896,147,688.51 |
| ACAD ACADIA Pharmaceuticals Inc | 7,538,571,203.39 | 1,494,297,312.61 |
| HALO Halozyme Therapeutics Inc | 7,505,877,229.83 | 2,786,100,812.91 |
| CRSP CRISPR Therapeutics AG | 6,565,093,457.65 | 2,915,277,900.07 |
| MYGN Myriad Genetics Inc | 6,414,805,591.16 | -1,018,015,943.26 |
| HRMY Harmony Biosciences Holdings Inc | 5,495,067,340.89 | 868,152,250.07 |
| RGEN Repligen Corp | 5,081,694,136.23 | -831,640,716.72 |
| NEO Neogenomics Inc | 5,075,462,051.45 | -467,438,987.28 |
| GH Guardant Health Inc | 5,059,212,950.82 | -6,102,972,951.1 |
| APLS Apellis Pharmaceuticals Inc | 4,776,093,580.96 | -2,890,121,159.93 |
| ITCI Intra-Cellular Therapies Inc | 4,310,220,772.06 | -932,496,078.28 |
| ANIP ANI Pharmaceuticals Inc | 4,295,700,993.38 | 37,686,167.13 |
| RARE Ultragenyx Pharmaceutical Inc | 4,156,637,405.23 | -4,019,531,540.05 |
| FOLD Amicus Therapeutics Inc | 3,754,977,909.67 | -1,104,253,639.99 |
| STRO Sutro Biopharma Inc | 3,710,570,227.02 | 1,013,611,066.58 |
| CHRS Coherus BioSciences Inc | 2,986,310,615.08 | -2,598,975,125.9 |
| VYGR Voyager Therapeutics Inc | 2,938,574,803.38 | 1,840,096,446.15 |
| CERT Certara Inc | 2,871,653,306.6 | -406,423,288.12 |
| MDXG MiMedx Group Inc | 2,833,216,679.0 | 2,045,428,956.76 |
| AGEN Agenus Inc | 2,734,319,040.41 | -1,585,168,287.03 |
| INSM Insmed Inc | 2,730,795,139.07 | -6,070,931,551.86 |
| KNSA Kiniksa Pharmaceuticals Ltd | 2,605,664,012.71 | -577,658,790.37 |
| LEGN Legend Biotech Corp | 2,592,808,298.55 | -4,725,225,412.51 |
| AMRN Amarin Corporation PLC | 2,437,789,268.22 | -188,626,607.95 |
| MRVI Maravai LifeSciences Holdings Inc | 2,419,125,642.59 | -3,588,571,457.41 |
| ADMA ADMA Biologics Inc | 2,411,382,195.68 | -575,718,360.62 |
| SPRO Spero Therapeutics Inc | 2,398,928,467.31 | 1,670,296,607.41 |
| PBYI Puma Biotechnology Inc | 2,355,075,472.83 | 400,289,089.48 |
| BPMC Blueprint Medicines Corp | 2,347,864,526.57 | -3,619,046,678.28 |
| AXSM Axsome Therapeutics Inc | 2,333,932,064.78 | -3,218,855,474.94 |
| TWST Twist Bioscience Corp | 2,332,887,945.86 | -1,403,295,823.32 |
| RVNC Revance Therapeutics Inc | 2,277,451,757.16 | -1,817,386,859.72 |
| MIRM Mirum Pharmaceuticals Inc | 2,269,457,721.71 | -1,163,507,388.48 |
| CSTL Castle Biosciences Inc | 2,157,410,710.52 | -84,182,087.62 |
| ZLAB Zai Lab Ltd | 2,147,948,382.84 | -3,113,725,751.57 |
| VCEL Vericel Corp | 2,120,736,033.59 | 423,944,908.68 |
| ACLX Arcellx Inc | 2,060,438,166.18 | 647,484,242.88 |
| SANG Sangoma Technologies Corp | 2,031,985,925.71 | -105,684,411.55 |
| EDIT Editas Medicine Inc | 1,959,321,774.89 | -615,834,388.24 |
| PTGX Protagonist Therapeutics Inc | 1,957,722,967.8 | 891,905,955.41 |
| MNKD MannKind Corp | 1,907,866,289.55 | 45,712,831.3 |
| CTKB Cytek Biosciences Inc | 1,900,068,026.4 | 179,555,824.86 |
| DVAX Dynavax Technologies Corp | 1,814,026,101.96 | 7,145,688.83 |
| DCPH Deciphera Pharmaceuticals Inc | 1,575,771,216.78 | -1,539,749,114.17 |
| KYMR Kymera Therapeutics Inc | 1,562,426,071.89 | -468,809,393.36 |
| ADPT Adaptive Biotechnologies Corp | 1,493,873,139.3 | -2,266,619,023.4 |
| VNDA Vanda Pharmaceuticals Inc | 1,477,134,607.92 | -78,308,918.71 |
| TVTX Travere Therapeutics Inc | 1,470,217,320.1 | -2,890,773,734.25 |
| ME 23andMe Holding Co. | 1,460,037,160.67 | -9,069,999,994.95 |
| TGTX TG Therapeutics Inc | 1,434,717,276.95 | -470,375,571.73 |
| ANIK Anika Therapeutics Inc | 1,402,088,560.82 | -2,055,609,116.19 |
| KRYS Krystal Biotech Inc | 1,375,071,983.87 | 283,608,800.6 |
| TRDA Entrada Therapeutics Inc | 1,365,446,512.61 | -311,408,466.74 |
| ROIV Roivant Sciences Ltd | 1,211,830,517.07 | 165,514,546,307.59 |
| KMDA Kamada Ltd | 1,188,729,386.05 | 165,036,046.19 |
| DNA Ginkgo Bioworks Holdings Inc | 1,134,011,029.1 | -6,907,303,432.42 |
| CDMO Avid Bioservices Inc | 1,103,340,035.94 | -195,968,069.08 |
| RCUS Arcus Biosciences Inc | 1,011,490,200.03 | -2,642,926,006.53 |
| ARCT Arcturus Therapeutics Holdings Inc | 1,006,759,036.19 | -381,984,379.73 |
| WVE WAVE Life Sciences Ltd | 948,059,975.87 | -530,412,409.41 |
| LGND Ligand Pharmaceuticals Inc | 916,899,551.97 | 593,451,088.97 |
| CTMX CytomX Therapeutics Inc | 868,152,250.07 | 27,310,235.4 |
| CDXS Codexis Inc | 866,651,329.13 | -234,665,726.41 |
| AKYA Akoya Biosciences Inc | 864,236,804.14 | -352,455,391.64 |
| ALIM Alimera Sciences Inc | 858,331,006.52 | -123,369,175.69 |
| PSTX Poseida Therapeutics Inc | 815,554,759.67 | -827,105,325.18 |
| RYTM Rhythm Pharmaceuticals Inc | 790,724,306.69 | -1,358,431,338.64 |
| URGN Urogen Pharma Ltd | 767,753,690.54 | -848,868,678.84 |
| YMAB Y-mAbs Therapeutics Inc | 762,304,694.95 | -32,237,171.54 |
| AYTU Aytu Biopharma Inc | 748,306,975.73 | -7,178,317.55 |
| RGNX Regenxbio Inc | 724,781,671.4 | -2,051,987,328.7 |
| CDXC Chromadex Corp | 691,598,267.09 | 3,719,673.64 |
| FBIO Fortress Biotech Inc | 650,812,371.93 | -945,710,708.31 |
| CDTX Cidara Therapeutics Inc | 573,710,715.71 | -183,079,726.21 |
| TELA TELA Bio Inc | 554,622,916.78 | -420,584,150.92 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股營收排名、龍頭是誰？
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例